GILBOA THERAPEUTICS
Gilboa Therapeutics a next-generation cancer immunotherapy company focused on the development of novel and transformative cell therapies designed to harness the power of a patient's own immune system to more effective treat a wide range of cancer types, with a mission to dramatically improve patient outcomes and save lives.
GILBOA THERAPEUTICS
Social Links:
Industry:
Biotechnology
Founded:
2021-01-01
Address:
Rehovot, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.gilboa.bio
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business Google GStatic Google Static Content Google Cloud
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
RootPath Genomics
RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
Current Advisors List
Current Employees Featured
Investors List
NFX
NFX investment in Seed Round - Gilboa Therapeutics
Official Site Inspections
http://www.gilboa.bio
- Host name: a67c48129651a0940.awsglobalaccelerator.com
- IP address: 76.223.67.189
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Gilboa Therapeutics"
Gilboa Therapeutics
Gilboa’s proprietary SolidT technology, originated in Dr. Yaron Carmi’s lab at Tel Aviv University. The technology is an engineered T cell therapy that is intended to be used in combination with …See details»
Gilboa Therapeutics 2025 Company Profile: Valuation, …
Gilboa Therapeutics was founded in 2019. Where is Gilboa Therapeutics headquartered? Gilboa Therapeutics is headquartered in Rehovot, Israel. What industry is Gilboa Therapeutics in? Gilboa Therapeutics’s primary industry is …See details»
Gilboa Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Gilboa Therapeutics a next-generation cancer immunotherapy company focused on the development of novel and …See details»
Gilboa Therapeutics - Israeli Startup | Startup Nation Finder
Jul 8, 2022 Gilboa Therapeutics Overview Gilboa Therapeutics is a preclinical-stage cancer immunotherapy company with a mission to dramatically improve outcomes and save lives. The …See details»
Gilboa Therapeutics - Products, Competitors, Financials, …
Gilboa Therapeutics is a preclinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies. Use the CB Insights Platform to explore …See details»
Gilboa Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore Gilboa Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Neoplasms, Technology Platform:T-lymphocyte cell therapy, …See details»
Gilboa Therapeutics - BIO International Convention | BIO
Jun 6, 2023 Gilboa is a preclinical-stage biopharmaceutical company, co-located in Boston and Israel, that is developing our proprietary SolidT technology, which originated in Dr. Yaron …See details»
Gilboa Therapeutics, Inc. - VentureRadar
Doma Bio China n/a Doma is an innovative biotechnology company with an independent drug research and development pipeline that also functions as a biotech incubator with flexible and …See details»
Gilboa Therapeutics Appoints Barry Labinger as CEO to …
Jun 14, 2022 Gilboa Therapeutics Inc., a preclinical-stage biopharmaceutical company developing a novel cell therapy platform to target solid tumors, today announced the appointment of Barry Labinger as Chief ...See details»
Gilboa Therapeutics - Leadership Team - The Org
The Leadership Team at Gilboa Therapeutics is responsible for guiding the strategic vision and operational execution of the company. Comprising the CEO, COO, CTO, and key VPs, this …See details»
Gilboa Therapeutics - Next-generation Cell Therapy for the …
Gilboa Therapeutics is a preclinical-stage cancer immunotherapy company with a mission to dramatically improve outcomes and save lives. The company is focu... Log in Sign up. …See details»
NEWS - Gilboa Therapeutics
Gilboa Therapeutics, a preclinical stage biotechnology company, today announced the presentation of pre-clinical data at the annual meeting of the American Association for Cancer …See details»
Jim Wooldridge - Acting CMO at Gilboa Therapeutics | The Org
Jim is the Acting Chief Medical Officer at Gilboa Therapeutics and brings more than 20 years of drug development experience in academia and industry. He received a medical degree from …See details»
Welcome to BIO 2025: Collaboration can't wait. | BIO
1 day ago As we kick off BIO 2025, the world’s largest biotech gathering, BIO emphasizes that collaboration can’t wait. Today’s theme: Collaboration—between government and industry, …See details»
Gilboa Therapeutics to Present at the H. | Gilboa Therapeutics
Jan 6, 2022 Gilboa Therapeutics Inc., a preclinical-stage biopharmaceutical company focused on the discovery and development of next-generation cell therapies, today announced that’s …See details»
BIO 2025: Progress can't wait. | BIO - bio.org
21 hours ago BIO 2025 started with a multi-panel session featuring officials from the Administration for Strategic Preparedness and Response (ASPR) and the Department of …See details»
BIO International Convention Opens in Boston, Showcasing Global ...
1 day ago The world’s largest biotech gathering unites 20,000+ leaders to accelerate breakthroughs that heal, protect, and nourish humanity. BOSTON (June 16, 2025) The BIO …See details»
How ADAMA's Gilboa Is a Major Breakthrough in Fungicide …
Dec 27, 2024 As European farmers face escalating challenges from fungal diseases and the increasing threat of fungicide resistance, Gilboa stands out as a transformative solution. …See details»
Gilboa Therapeutics - BIO International Convention | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. Gilboa Therapeutics - BIO …See details»
Innovative fungicide mode of action in development | ADAMA
Dec 20, 2024 The new molecule, GILBOA â„¢, provides protection against a range of diseases including septoria, ramularia and sclerotinia, and has been submitted to the Fungicide …See details»